Antibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1045363 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Troponin I Type 3 (Cardiac) (TNNI3) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant Human Cardiac Troponin I protein
- Description
- Caprylic Acid Ammonium Sulfate Precipitation purified
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Feline, Goat, Porcine, Rabbit, Simian
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- 4°C
Submitted references Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.
Prognosis based on creatine kinase isoenzyme MB, cardiac troponin I, and right ventricular size in stable patients with acute pulmonary embolism.
Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.
Postoperative cardiac troponin I (cTnI) level and its prognostic value for patients undergoing mitral valve surgery.
Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction.
Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality.
Troponin-I as a prognosticator of mortality in severe sepsis patients.
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease.
Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome.
[Clinical usefulness of troponin I in acute pulmonary embolism].
Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB.
Goel S, Beith JM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 1;29(7):e175-6
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 1;29(7):e175-6
Prognosis based on creatine kinase isoenzyme MB, cardiac troponin I, and right ventricular size in stable patients with acute pulmonary embolism.
Stein PD, Janjua M, Matta F, Pathak PK, Jaweesh F, Alrifai A, Chughtai HL
The American journal of cardiology 2011 Mar 1;107(5):774-7
The American journal of cardiology 2011 Mar 1;107(5):774-7
Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.
Xue Y, Clopton P, Peacock WF, Maisel AS
European journal of heart failure 2011 Jan;13(1):37-42
European journal of heart failure 2011 Jan;13(1):37-42
Postoperative cardiac troponin I (cTnI) level and its prognostic value for patients undergoing mitral valve surgery.
Oshima K, Kunimoto F, Takahashi T, Mohara J, Takeyoshi I, Hinohara H, Okawa M, Saito S
International heart journal 2010 May;51(3):166-9
International heart journal 2010 May;51(3):166-9
Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, Jarolim P, Braunwald E, Morrow DA
Journal of the American College of Cardiology 2010 May 11;55(19):2118-24
Journal of the American College of Cardiology 2010 May 11;55(19):2118-24
Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction.
Paparella D, Scrascia G, Paramythiotis A, Guida P, Magari V, Malvindi PG, Favale S, de Luca Tupputi Schinosa L
The Annals of thoracic surgery 2010 Mar;89(3):696-702
The Annals of thoracic surgery 2010 Mar;89(3):696-702
Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality.
van Geene Y, van Swieten HA, Noyez L
Interactive cardiovascular and thoracic surgery 2010 Mar;10(3):413-6
Interactive cardiovascular and thoracic surgery 2010 Mar;10(3):413-6
Troponin-I as a prognosticator of mortality in severe sepsis patients.
John J, Woodward DB, Wang Y, Yan SB, Fisher D, Kinasewitz GT, Heiselman D
Journal of critical care 2010 Jun;25(2):270-5
Journal of critical care 2010 Jun;25(2):270-5
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M
American heart journal 2010 Jan;159(1):63-7
American heart journal 2010 Jan;159(1):63-7
Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S
Coronary artery disease 2010 Aug;21(5):261-5
Coronary artery disease 2010 Aug;21(5):261-5
Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease.
Fruchter O, Yigla M
COPD 2009 Jun;6(3):155-61
COPD 2009 Jun;6(3):155-61
Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome.
Zahid M, Good CB, Singla I, Sonel AF
The American journal of cardiology 2009 Jul 15;104(2):164-8
The American journal of cardiology 2009 Jul 15;104(2):164-8
[Clinical usefulness of troponin I in acute pulmonary embolism].
Alonso Martínez JL, Annicchérico Sánchez FJ, Urbieta Echezarreta MA, García Sanchotena JL, Ezcurra Ibáñez M, Lasa Inchausti B
Medicina clinica 2009 Jul 11;133(6):201-5
Medicina clinica 2009 Jul 11;133(6):201-5
Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB.
Apple FS
Clinica chimica acta; international journal of clinical chemistry 1999 Jun 30;284(2):151-9
Clinica chimica acta; international journal of clinical chemistry 1999 Jun 30;284(2):151-9
No comments: Submit comment
No validations: Submit validation data